This month, we welcome back Glycologix, who recently rejoined NSIV. At Glycologix, what began as a potential cure for wrinkles has evolved into what could become the first treatment on the market for a debilitating urology disease. The company is developing a compound that mimics the properties of proteogylcans, molecules which provide hydration and performRead more